Tridecanediamidine 2HCl

Suppliers

Names

[ CAS No. ]:
6033-13-2

[ Name ]:
Tridecanediamidine 2HCl

Chemical & Physical Properties

[ Density]:
1.04g/cm3

[ Boiling Point ]:
370.5ºC at 760 mmHg

[ Molecular Formula ]:
C13H29ClN4

[ Molecular Weight ]:
276.84900

[ Flash Point ]:
177.9ºC

[ Exact Mass ]:
276.20800

[ PSA ]:
99.74000

[ LogP ]:
5.55150

[ Index of Refraction ]:
1.524

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
YD3325000
CHEMICAL NAME :
Tridecanediamidine, dihydrochloride
CAS REGISTRY NUMBER :
6033-13-2
LAST UPDATED :
198611
DATA ITEMS CITED :
4
MOLECULAR FORMULA :
C13-H28-N4.2Cl-H
MOLECULAR WEIGHT :
313.37
WISWESSER LINE NOTATION :
ZNU13

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
25 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ATMPA2 Annals of Tropical Medicine and Parasitology. (Grune & Stratton, Inc., POB 6280, Duluth, MN 55806) V.1- 1907- Volume(issue)/page/year: 32,177,1938
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
26 mg/kg
TOXIC EFFECTS :
Endocrine - hyperglycemia
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 57,81,1936
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Unreported
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
25 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ATMPA2 Annals of Tropical Medicine and Parasitology. (Grune & Stratton, Inc., POB 6280, Duluth, MN 55806) V.1- 1907- Volume(issue)/page/year: 32,177,1938
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
20 mg/kg
TOXIC EFFECTS :
Endocrine - hyperglycemia
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 57,81,1936

Related Compounds

  • Eprazinone 2HCl
  • Puromycin 2HCl
  • Quisinostat 2HCl
  • ABT594 2HCL
  • EFLETIRIZINE 2HCL
  • ZIMELIDINE 2HCL
  • n3-(2-Ethoxy-phenyl)-1-pyridin-2-yl-1h-[1,2,4]triazole-3,5-diamine
  • 2-[5-Amino-3-(2-methoxy-phenylamino)-[1,2,4]triazol-1-yl]-pyrimidine-5-carbonitrile
  • N3-1,3-Benzodioxol-5-yl-1-(6-chloro-4-pyrimidinyl)-1H-1,2,4-triazole-3,5-diamine
  • 1-Cyclopropyl-4-(4-nitro-phenyl)-piperazine
  • 4-[5-Amino-3-(benzo[1,3]dioxol-5-ylamino)-[1,2,4]triazol-1-yl]-benzamide
  • n3-(3-Morpholin-4-ylmethyl-phenyl)-1-pyridin-2-yl-1h-[1,2,4]triazole-3,5-diamine
  • 4-[5-Amino-3-(benzo[1,3]dioxol-5-ylamino)-[1,2,4]triazol-1-yl]-benzonitrile
  • [3,5-Dimethoxy-4-(3-morpholin-4-yl-propoxy)-phenyl]-carbamic acid tert-butyl ester
  • n3-(3,5-Dimethyl-phenyl)-1-thiazol-2-yl-1h-[1,2,4]triazole-3,5-diamine
  • n3-(3,4-Dimethoxy-phenyl)-1-thiazol-2-yl-1h-[1,2,4]triazole-3,5-diamine
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.